William Zuo
Corporate Officer/Principal presso ATHENEXPAR
Profilo
William Zuo is currently the Chairman & President of Polymed Therapeutics at Chongqing Taihao Pharmaceutical Co., Ltd.
and the President of China Operations at Athenex, Inc. He was previously the Chief Executive Officer of Fibrocell Science, Inc. from 2010 to 2013 and the Chairman & Chief Executive Officer of InovaChem, Inc. from 2008 to 2010.
He also served as a Director at Polymed Therapeutics, Inc. Dr. Zuo holds graduate and doctorate degrees from Rice University.
Posizioni attive di William Zuo
| Società | Posizione | Inizio |
|---|---|---|
| ATHENEXPAR | Corporate Officer/Principal | 01/01/2015 |
| Chongqing Taihao Pharmaceutical Co., Ltd. | Chairman | 01/01/2012 |
Precedenti posizioni note di William Zuo
| Società | Posizione | Fine |
|---|---|---|
| FIBROCELL SCIENCE, INC. | Chief Executive Officer | 01/01/2013 |
InovaChem, Inc.
 InovaChem, Inc. Chemicals: SpecialtyProcess Industries InovaChem, Inc. is a development stage company which develops, manufactures, and markets chemicals and other related products. It helps to minimize the cost of manufacture of food, pharmaceutical, and other products, including sucralose, through the utilization of technologies. The company was founded in February 2008 and is headquartered in Houston, Texas | Chairman | 29/01/2010 |
Polymed Therapeutics, Inc.
 Polymed Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polymed Therapeutics, Inc. manufactures of application programming interface and chemical. It offers active pharmaceutical ingredients, rapid diagnostic tests, food additives, lanolin products. The company was founded on November 16, 1999 and is headquartered in Houston, TX. | Director/Board Member | - |
Formazione di William Zuo
| Rice University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
Athenex, Inc.
 Athenex, Inc. Pharmaceuticals: MajorHealth Technology Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY. | Health Technology |
InovaChem, Inc.
InovaChem, Inc. Chemicals: SpecialtyProcess Industries InovaChem, Inc. is a development stage company which develops, manufactures, and markets chemicals and other related products. It helps to minimize the cost of manufacture of food, pharmaceutical, and other products, including sucralose, through the utilization of technologies. The company was founded in February 2008 and is headquartered in Houston, Texas | Process Industries |
Polymed Therapeutics, Inc.
Polymed Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Polymed Therapeutics, Inc. manufactures of application programming interface and chemical. It offers active pharmaceutical ingredients, rapid diagnostic tests, food additives, lanolin products. The company was founded on November 16, 1999 and is headquartered in Houston, TX. | Health Technology |
| Chongqing Taihao Pharmaceutical Co., Ltd. |
- Borsa valori
- Insiders
- William Zuo
